Microglia-neuron crosstalk in Alzheimer's disease: an exploration of molecular mechanisms and pathological

Xizhen Kang1, Jun Tian1, Qing Shu1

  • 1Department of Rehabilitation Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.

Neuroscience
|July 12, 2025
PubMed

Insights

Microglia and neuron communication disruptions drive Alzheimer's disease (AD) progression. Targeting these interactions offers new therapeutic strategies for neurodegeneration and preserving brain health.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the central nervous system (CNS) immune cells.
  • Neurons are the primary information transmitters in the CNS.
  • Homeostasis in the CNS relies on microglia-neuron interactions.

Purpose of the Study:

  • To review the molecular mechanisms of microglia-neuron interactions in Alzheimer's disease (AD).
  • To explore how disrupted communication contributes to AD pathogenesis.
  • To identify potential therapeutic targets for AD.

Main Methods:

  • Review of current literature on microglia-neuron communication in AD.
  • Analysis of molecular pathways involved in the crosstalk.
  • Discussion of therapeutic strategies targeting these interactions.

Main Results:

  • Disrupted microglia-neuron crosstalk in AD involves neurotransmitter signaling, synaptic elimination, molecular secretion, and direct cell contact.
  • Dysfunctional communication leads to microglial hyperactivation, oxidative stress, accelerated memory loss, and neuroinflammation.
  • Specific pathways like TREM2, complement cascade, and inflammasome are implicated.

Conclusions:

  • Understanding microglia-neuron crosstalk is crucial for developing effective AD therapies.
  • Targeting specific pathways may halt neurodegeneration while maintaining immune function.
  • Advanced techniques like spatiotemporal omics and live imaging can track these interactions and identify therapeutic windows.